These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 26859106)

  • 1. Differential Effects of Teriparatide and Denosumab on Intact PTH and Bone Formation Indices: AVA Osteoporosis Study.
    Dempster DW; Zhou H; Recker RR; Brown JP; Recknor CP; Lewiecki EM; Miller PD; Rao SD; Kendler DL; Lindsay R; Krege JH; Alam J; Taylor KA; Janos B; Ruff VA
    J Clin Endocrinol Metab; 2016 Apr; 101(4):1353-63. PubMed ID: 26859106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to Therapy With Teriparatide, Denosumab, or Both in Postmenopausal Women in the DATA (Denosumab and Teriparatide Administration) Study Randomized Controlled Trial.
    Leder BZ; Tsai JN; Neer RM; Uihlein AV; Wallace PM; Burnett-Bowie SA
    J Clin Densitom; 2016; 19(3):346-51. PubMed ID: 26900146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Teriparatide and denosumab combination therapy and skeletal metabolism.
    Idolazzi L; Rossini M; Viapiana O; Braga V; Fassio A; Benini C; Kunnathully V; Adami S; Gatti D
    Osteoporos Int; 2016 Nov; 27(11):3301-3307. PubMed ID: 27250971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial.
    Leder BZ; Tsai JN; Uihlein AV; Wallace PM; Lee H; Neer RM; Burnett-Bowie SA
    Lancet; 2015 Sep; 386(9999):1147-55. PubMed ID: 26144908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of treatments for postmenopausal osteoporosis (bisphosphonates, parathyroid hormone, strontium ranelate, and denosumab) on bone quality: a systematic review.
    Gallacher SJ; Dixon T
    Calcif Tissue Int; 2010 Dec; 87(6):469-84. PubMed ID: 20872215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parathyroid Hormone and Parathyroid Hormone-Related Protein Analogs in Osteoporosis Therapy.
    Leder BZ
    Curr Osteoporos Rep; 2017 Apr; 15(2):110-119. PubMed ID: 28303448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of 4-year denosumab treatment alone or in combination with teriparatide in Japanese postmenopausal osteoporotic women.
    Suzuki T; Nakamura Y; Kato H
    Mod Rheumatol; 2019 Jul; 29(4):676-681. PubMed ID: 30217118
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture and Strength (DATA-HRpQCT study).
    Tsai JN; Uihlein AV; Burnett-Bowie SM; Neer RM; Derrico NP; Lee H; Bouxsein ML; Leder BZ
    J Clin Endocrinol Metab; 2016 May; 101(5):2023-30. PubMed ID: 26964731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating noggin levels following treatment with denosumab or teriparatide in postmenopausal women with low bone mass.
    Anastasilakis AD; Polyzos SA; Makras P; Rauner M; Sonnleitner L; Hawa G; Tsourdi E; Yavropoulou MP; Missbichler A; Terpos E
    J Musculoskelet Neuronal Interact; 2019 Sep; 19(3):253-257. PubMed ID: 31475931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of prompt antiresorptive therapy in postmenopausal women discontinuing teriparatide or denosumab: The Denosumab and Teriparatide Follow-up study (DATA-Follow-up).
    Leder BZ; Tsai JN; Jiang LA; Lee H
    Bone; 2017 May; 98():54-58. PubMed ID: 28286299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of osteoporosis with PTH].
    Takeuchi Y
    Clin Calcium; 2014 Jun; 24(6):893-902. PubMed ID: 24870841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixed-treatment comparison of anabolic (teriparatide and PTH 1-84) therapies in women with severe osteoporosis.
    Migliore A; Broccoli S; Massafra U; Bizzi E; Frediani B
    Curr Med Res Opin; 2012 Mar; 28(3):467-73. PubMed ID: 22256908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of postmenopausal osteoporosis and the prevention of fractures.
    Gambacciani M; Levancini M
    Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined teriparatide and denosumab therapy accelerates spinal fusion following posterior lumbar interbody fusion.
    Ide M; Yamada K; Kaneko K; Sekiya T; Kanai K; Higashi T; Saito T
    Orthop Traumatol Surg Res; 2018 Nov; 104(7):1043-1048. PubMed ID: 30179720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined Pharmacologic Therapy in Postmenopausal Osteoporosis.
    Shen Y; Gray DL; Martinez DS
    Endocrinol Metab Clin North Am; 2017 Mar; 46(1):193-206. PubMed ID: 28131133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Parathyroid and bone. Role of parathyroid hormone in the treatment of osteoporosis].
    Nakamura T
    Clin Calcium; 2007 Dec; 17(12):1823-9. PubMed ID: 18057656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTH (1-34): a novel anabolic drug for the treatment of osteoporosis.
    Holick MF
    South Med J; 2005 Nov; 98(11):1114-7. PubMed ID: 16353381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using Osteoporosis Therapies in Combination.
    McClung MR
    Curr Osteoporos Rep; 2017 Aug; 15(4):343-352. PubMed ID: 28667435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination and sequential treatment in women with postmenopausal osteoporosis.
    Anastasilakis AD; Polyzos SA; Yavropoulou MP; Makras P
    Expert Opin Pharmacother; 2020 Mar; 21(4):477-490. PubMed ID: 31990595
    [No Abstract]   [Full Text] [Related]  

  • 20. A novel tetracycline labeling schedule for longitudinal evaluation of the short-term effects of anabolic therapy with a single iliac crest bone biopsy: early actions of teriparatide.
    Lindsay R; Cosman F; Zhou H; Bostrom MP; Shen VW; Cruz JD; Nieves JW; Dempster DW
    J Bone Miner Res; 2006 Mar; 21(3):366-73. PubMed ID: 16491283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.